NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.

Therapeutics

Life Sciences

Health Care

Biotechnology

NextPoint Therapeutics, Inc.

Paul Conrad

Stephanie D.

Bijan Etemad-Gilbertson

Michael O'Meara

Scientific Research and Development

Business Operations and Development

Leadership Team

Teams at NextPoint Therapeutics, Inc.

Scientific Research and Development

Business Operations and Development

Leadership Team